# FDA Inspection 1060256 - Chongqing Taihao Pharmaceutical Co., Ltd. - May 10, 2018

Source: https://www.globalkeysolutions.net/records/fda_inspections/chongqing-taihao-pharmaceutical-co-ltd/a234efbe-d0a6-478a-ba4a-8305abb3b913
Source feed: FDA_Inspections

> FDA Inspection 1060256 for Chongqing Taihao Pharmaceutical Co., Ltd. on May 10, 2018. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1060256
- Company Name: Chongqing Taihao Pharmaceutical Co., Ltd.
- Inspection Date: 2018-05-10
- Classification: No Action Indicated (NAI)
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 920921 - 2015-03-13](https://www.globalkeysolutions.net/records/fda_inspections/chongqing-taihao-pharmaceutical-co-ltd/d78e8144-d4a9-4a27-8a62-cc899c8a4ddb)
- [FDA Inspection 784879 - 2012-05-23](https://www.globalkeysolutions.net/records/fda_inspections/chongqing-taihao-pharmaceutical-co-ltd/45af21ca-867e-4f09-85ed-b98d2b55f662)

Company: https://www.globalkeysolutions.net/companies/chongqing-taihao-pharmaceutical-co-ltd/827eb932-e32e-4fde-8c00-4b54c2302911

Office: https://www.globalkeysolutions.net/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c